Speaker illustration

Professor Heinz Drexel

Vorarlberg Institute for Vascular Investigation & Treatment (VIVIT), Feldkirch (Austria)

Member of:

European Society of Cardiology

CURRICULUM VITAE 1976 Medical degree with highest award of the Republic of Austria, University of Innsbruck. 1983-1987 Assistant Professor, leading physician of the Diabetes inpatient and outpatient clinic, University of Innsbruck. 1991-1994 Head of Lipid Research, Division of Cardiology, Department of Medicine, University Hospital of Zurich, Switzerland. Since 1994 Professor of Medicine; 1994–2016 Head of Department of Medicine, County Hospital of Feldkirch (since 2000 designated “Academic Teaching Hospital of Feldkirch”), Austria. Since 1997: Head of the research institute VIVIT at the Academic Teaching Hospital Feldkirch, Austria Since 2006 Dean of the Medical Faculty and Full Professor of Medicine (Cardiology and Endocrinology), Private University of the Principality of Liechtenstein. 2018-2020 President of the ESC-Working Group “Cardiovascular Pharmacotherapy” Since 2020 Head of the Department of Internat Medicine & Intensive Care, County Hospital Bregenz, Austria

Lipid management in patients with acute coronary syndrome: strike early and strong!!

Event: ESC Acute CardioVascular Care 2022

Topic: Lipid-Lowering Agents

Session type: Symposium

Thumbnail

Latest insights into cholesterol management for the post-myocardial infarction patient

Event: ESC CONGRESS 2019

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium

Thumbnail

PCSK9 inhibitors: from cells to patients

Event: ESC CONGRESS 2019

Topic: PCSK9-Antagonists

Session type: Advances in Science

Thumbnail

How to implement PCSK9 inhibitor treatment in my practice

Event: ESC CONGRESS 2019

Topic: Pharmacology and Pharmacotherapy

Session type: HowTo

Thumbnail

PCSK9 inhibitors - For the many or the few?

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy

Session type: Advances in Science

Thumbnail

Are generic drugs safe in heart failure ?

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy

Session type: Symposium

Thumbnail

Recent results in clinical trials of blood cholesterol lowering

Event: ESC CONGRESS 2017

Topic: Lipids (Epidemiology and Prevention)

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Cholesteryl ester transfer protein (CETP) inhibition: emerging science in LDL lowering

Event: ESC CONGRESS 2016

Topic: Atherosclerosis

Session type: Satellite Symposium

Thumbnail

PCSK9 inhibitors: ready to embrace?

Event: ESC CONGRESS 2016

Topic: Drug therapy

Session type: Debate Session

Thumbnail

Still learning of DAPT: Clopidogrel out of the game?

Event: ESC CONGRESS 2016

Topic: Drug therapy

Session type: Advances in Science

Thumbnail

This platform is supported by

logo Novo Nordisk